natgillin/translations-raw huggingface dataset:
What is Clopidogrel Mylan? 
Kaj je zdravilo Clopidogrel Mylan?
How is Clopidogrel Mylan used? 
Kako se zdravilo Clopidogrel Mylan uporablja?
How does Clopidogrel Mylan work? 
Kako zdravilo Clopidogrel Mylan deluje?
It may help you by: 
Pomaga vam lahko tako, da:
• improving your ability to perform daily activities. 
• izboljša sposobnost za opravljanje vsakodnevnih dejavnosti.
Date of first authorisation: 23 June 2017 
Datum prve odobritve: 23. junij 2017
• The injection can take up to 15 seconds. 
• Injiciranje lahko traja do 15 sekund.
• You may see an air bubble, this is normal. 
• Morda boste videli mehurček zraka, to je normalno.
You will also have the tests during your treatment. 
Preiskave boste opravljali tudi med zdravljenjem.
Date of removal from the refrigerator: .../.../... 
Datum odstranitve iz hladilnika: .../.../...
Prepare all the equipment you will need on a clean, flat working surface. 
Pripravite vse, kar boste potrebovali, na čisti, ravni delovni površini.
50 to 100 
Od 50 do 100
Less than 50 
Manj kot 50
Percentage of Patients 
Odstotek bolnikov
• you have ever had any type of cancer. 
• ste kdaj imeli kakršno koli vrsto raka.
Component of a multipack, can't be sold separately. 
Del skupnega pakiranja, ni mogoče prodati ločeno.
• Make sure you can see the window. 
• Prepričajte se, da lahko vidite okence.
• There will be a “click” when the injection starts. 
• Slišali boste “klik”, ko se bo injiciranje začelo.
Look at the label. 
Poglejte nalepko.
The patient alert card shall contain the following key messages: 
Opozorilna kartica bolnika mora obsegati naslednja ključna sporočila:
• Your doctor may adjust the dose of your medicine based on results of blood tests. 
• Zdravnik vam lahko prilagodi odmerek zdravila glede na rezultate preiskav krvi.
Simvastatin is a CYP3A4 and OATP1B1 substrate. 
Simvastatin je substrat CYP3A4 in OATP1B1.
Fatigue was assessed by the FACIT-Fatigue scale. 
Utrujenost so ocenjevali z lestvico FACIT-Fatigue.
As there is a higher incidence of infections in the elderly population in general, caution should be used when treating the elderly. 
Ker je pojavnost okužb v starejši populaciji na splošno večja, je pri zdravljenju starejših oseb potrebna previdnost.
• Slowly push the plunger down as far as it will go until the syringe is empty. 
• Počasi potisnite bat, kolikor daleč gre, dokler ni brizga prazna.
Interactions with CYP450 substrates 
Medsebojna delovanja s substrati CYP450
General health status was assessed by the Short Form health survey (SF-36). 
Splošno zdravstveno stanje so ocenjevali z vprašalnikom SF-36 (Short Form health survey).
Do not press or touch the yellow needle cover with your fingers. 
Ne pritiskajte ali dotikajte se rumenega pokrovčka igle s prsti.
Step B: Perform the injection - Perform Step B only after completing Step A “Get ready for an injection” 
Korak B: Injicirajte - Korak B opravite, šele ko ste dokončali korak A "Pripravite se za injiciranje"
Age, gender, ethnicity and body weight 
Starost, spol, etnična pripadnost in telesna masa
• If you do not hear the second click, you should still check to see if the window has turned fully yellow. 
• Če ne slišite še enega klika, morate še vedno preveriti, če se je okence v celoti obarvalo rumeno.
Do not inject through your clothes. 
Ne injicirajte skozi obleko.
Sarilumab was detected in the serum of neonates up to 1 month. 
Sarilumab je bil zaznan v serumu novorojenčkov do 1 meseca.
• The effects of Kevzara on an unborn baby are not known. 
• Učinki zdravila Kevzara na nerojenega otroka niso znani.
• if you are allergic to sarilumab or any of the other ingredients of this medicine (listed in section 6). 
• če ste alergični na sarilumab ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
The detection of an immune response is highly dependent on the sensitivity and specificity of the assays used and testing conditions. 
Odkritje imunskega odziva je močno odvisno od senzitivnosti in specifičnosti uporabljenega preizkusa in od pogojev testiranja.
Patients should be managed according to clinical guidelines for the management of hyperlipidaemia. 
Bolnike je treba voditi v skladu s kliničnimi smernicami za vodenje hiperlipidemije.
In MOBILITY and TARGET, physical function and disability were assessed by the Health Assessment Questionnaire Disability Index (HAQ-DI). 
V študijah MOBILITY in TARGET so telesno delovanje in invalidnost ocenjevali z indeksom HAQ-DI (Health Assessment Questionnaire Disability Index).
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. 
Obvestite svojega zdravnika ali farmacevta, če uporabljate, ste pred kratkim uporabljali ali pa boste morda začeli uporabljati katero koli drugo zdravilo.
Step A: Get ready for an injection 1. 
Korak A: Pripravite se za injiciranje
The subsequent dose should be administered at the regularly scheduled time. 
Naslednji odmerek je treba uporabiti ob redno predvidenem času.
There will be a second click. 
Slišali boste še en klik.
• been exposed to tuberculosis; or 
• so bili izpostavljeni tuberkulozi ali
Dose modification: 
Prilagoditev odmerka:
Levels were reduced to normal as early as 4 days after treatment initiation. 
Koncentracija se je znižala na normalno že 4 dni po uvedbi zdravljenja.
Look at the medicine. 
Preglejte zdravilo.
In order to improve the traceability of biological medicinal products, the name and the batch number of the administered product should be clearly recorded. 
Za izboljšanje sledljivosti bioloških zdravil je treba ime zdravila in številko serije uporabljenega zdravila jasno zabeležiti.
Table 6: Efficacy results for MONARCH 
Preglednica 6: Rezultati učinkovitosti v študiji MONARCH
Name and address of the manufacturer(s) responsible for batch release Sanofi Winthrop Industrie 
Ime in naslov izdelovalcev, odgovornih za sproščanje serij Sanofi Winthrop Industrie
• Check the expiry date (EXP). 
• Preverite datum izteka roka uporabnosti (EXP).
ALT > 1 to 3 x Upper Limit of Normal (ULN) 
ALT > 1- do 3-kratna zgornja normalna meja (ZNM)
The frequency of adverse reactions listed below is defined using the following convention: very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000). 
Pogostnost spodaj naštetih neželenih učinkov je opredeljena po naslednjem dogovoru: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000
• Check that you have the correct medicine and the correct dose. 
• Preverite, da imate pravo zdravilo in pravi odmerek.
Tell your doctor straight away if you think you have an infection (which may affect up to 1 in every 10 people). 
Zdravnika takoj obvestite, če menite, da imate okužbo (pojavi se lahko pri največ 1 od 10 oseb).
In the event of an overdose, the patient should be closely monitored, treated symptomatically, and supportive measures instituted as required. 
V primeru prevelikega odmerjanja je treba bolnika skrbno nadzirati, zdraviti simptomatsko in uvesti podporne ukrepe, kot je potrebno.
Kevzara should not be used during pregnancy unless the clinical condition of the woman requires treatment with sarilumab. 
Zdravila Kevzara se med nosečnostjo ne sme uporabljati, razen če klinično stanje ženske zahteva zdravljenje s sarilumabom.
Kevzara can be used alone or together with a medicine called methotrexate. 
Zdravilo Kevzara je mogoče uporabljati samo ali skupaj z zdravilom, imenovanim metotreksat.
Physician global VAS‡ (0-100 mm) Patient global VAS‡ (0-100 mm) HAQ-DI 
VAS† (0-100 mm) Zdravnikova celotna VAS‡ (0-100 mm) Bolnikova celotna VAS‡ (0-100 mm) HAQ-DI
For further details on administration of this medicinal product see section 6.6. 
Za dodatne podrobnosti o dajanju tega zdravila glejte poglavje 6.6.
Patients with severe renal impairment were not studied. 
Bolnikov s hudo okvaro ledvic niso raziskali.
Before you remove the needle, check that the syringe is empty. 
Preden iglo potegnete iz kože, se prepričajte, da je brizga prazna.
Hypercholesterolemia Hypertriglyceridemia 
Hiperholesterolemija Hipertrigliceridemija
At higher concentrations, the elimination is predominantly through the linear, non-saturable proteolytic pathway, while at lower concentrations, non-linear saturable target-mediated elimination predominates. 
Pri višjih koncentracijah je izločanje pretežno po linearni, nesaturabilni proteolitični poti, pri nižjih koncentracijah pa prevladuje nelinearno, saturabilno, ciljno posredovano izločanje.
Because IgG1 are excreted in human milk, a decision should be made whether to discontinue breastfeeding or to discontinue sarilumab therapy taking into account the benefit of breast-feeding for the child and the benefit of therapy for the woman. 
Ker se IgG1 pri človeku izločajo v materino mleko, se je treba odločiti bodisi za prenehanje dojenja bodisi za prenehanje zdravljenja s sarilumabom, upoštevaje koristi dojenja za otroka in koristi zdravljenja za žensko.
Check that you have the correct medicine and the correct dose. 
Preverite, da imate pravo zdravilo in pravi odmerek.
• if you have an active severe infection. 
• če imate kakšno aktivno, hudo okužbo.
Lipid levels may be reduced in patients with chronic inflammation. 
Vrednost lipidov je lahko pri bolnikih s kroničnimi vnetji znižana.
• other biological medicines used in the treatment of rheumatoid arthritis. 
• druga biološka zdravila za zdravljenje revmatoidnega artritisa.
p-value versus adalimumab 
Vrednost p v primerjavi z adalimumabom
• HIV infection; 
• okužbo z virusom HIV,
Women of childbearing potential should use effective contraception during and up to 3 months after treatment. 
Ženske v rodni dobi morajo uporabljati učinkovito kontracepcijo med zdravljenjem s tem zdravilom in še do 3 mesece po zdravljenju.
Check to see if the entire window has turned yellow before you remove the pen. 
Preverite, da je okence postalo rumeno, preden peresnik odstranite.
ANC 0.5-1 
AŠN 0,5-1
Of these, 2170 patients received Kevzara for at least 24 weeks, 1546 for at least 48 weeks, 1020 for at least 96 weeks, and 624 for at least 144 weeks. 
Od teh bolnikov jih je 2170 prejemalo zdravilo Kevzara vsaj 24 tednov, 1546 vsaj 48 tednov, 1020 vsaj 96 tednov in 624 vsaj 144 tednov.
• Clean skin with an alcohol wipe. 
• Kožo očistite z alkoholnim lističem.
Decrease in ANC was not associated with higher incidence of infections, including serious infections. 
Zmanjšanja AŠN ni spremljala večja pojavnost okužb, vključno z resnimi okužbami.
Table 3: Clinical Response at Weeks 12, 24, and 52 in Placebo-Controlled Studies, MOBILITY and TARGET 
Preglednica 3: Klinični odziv 12., 24. in 52. teden v študijah MOBILITY in TARGET, kontroliranih s placebom
Placebo-controlled studies 
S placebom kontrolirane študije
Treatment with immunosuppressants may result in an increased risk of malignancies. 
Zdravljenje z imunosupresivnimi zdravili lahko poveča tveganje za maligne bolezni.
• warfarin, used to prevent blood clots. 
• varfarin, ki se uporablja za preprečevanje krvnih strdkov.
These responses persisted through 3 years of therapy in an open-label extension study. 
Ti odzivi so trajali ves čas 3-letnega zdravljenja v podaljšani študiji z načrtom odprtega zdravljenja.
Patients should be advised to seek immediate medical attention if they experience any symptoms of a hypersensitivity reaction. 
Bolnikom je treba naročiti, naj nemudoma poiščejo zdravniško pomoč, če se jim pojavi kakšen simptom preobčutljivostne reakcije.
• statins, used to reduce cholesterol level 
• statine, ki se uporabljajo za znižanje koncentracije holesterola,
• lived in or travelled to areas of endemic tuberculosis or endemic mycoses. 
• so živeli na območju endemične tuberkuloze ali endemičnih mikoz ali so potovali na takšna območja.
• Check the expiry date (EXP), this is shown on the side of the pens. 
• Preverite datum izteka roka uporabnosti (EXP), to je prikazano na strani peresnikov.
If somebody else gives you the injection, you can also use the outer area of the upper arm. 
Če vam zdravilo injicira nekdo drug, lahko uporabi tudi zunanji del nadlakta.
When clinically indicated, consider other liver function tests such as bilirubin. 
Če je klinično indicirano, pridejo v poštev drugi testi jetrne funkcije, na primer bilirubin.
Component (range) 
Komponenta (razpon)
ANC greater than 1 
AŠN več kot 1
Kevzara can affect the way some medicines work: this means the dose of other medicines may need changing. 
Zdravilo Kevzara lahko vpliva na delovanje nekaterih zdravil: to pomeni, da bo morda treba spremeniti odmerek drugih zdravil.
These parallel elimination pathways result in an initial half-life of 8 to 10 days, and at steady-state an effective halflife of 21 days is estimated. 
Rezultat teh vzporednih poti izločanja je začetni razpolovni čas od 8 do 10 dni in efektivni razpolovni čas v stanju dinamičnega ravnovesja, ki je ocenjen na 21 dni.
The safety of Kevzara in combination with DMARDs was evaluated based on data from seven clinical studies, of which two were placebo-controlled, consisting of 2887 patients (long- term safety population). 
Varnost zdravila Kevzara v kombinaciji z DMARD so ocenili na podlagi podatkov iz sedmih kliničnih študij, od katerih sta bili dve kontrolirani s placebom; te študije so zajele 2887 bolnikov (dolgoročna varnostna populacija).
In addition to this leaflet, you will be given a patient alert card, which contains important safety information that you need before and during treatment with Kevzara. 
Poleg navodila za uporabo boste prejeli opozorilno kartico, ki vsebuje pomembne varnostne informacije, ki jih potrebujete pred in med zdravljenjem z Kevzara.
Two patients on Kevzara (0.2%) discontinued treatment due to injection site reactions. 
Dva bolnika na zdravilu Kevzara (0,2 %) sta zdravljenje prenehala zaradi reakcij na mestu injiciranja.
• then inject your next dose at your regular time. 
• nato injicirajte naslednji odmerek ob običajnem času.
For these reasons, comparison of the incidence of antibodies to Kevzara with the incidence of antibodies to other products may be misleading. 
Zato je lahko primerjava pojavnosti protiteles proti zdravilu Kevzara s pojavnostjo protiteles proti drugim zdravilom lahko zavajajoča.
These injection site reactions (including erythema and pruritus) were mild in severity for the majority of patients. 
Te reakcije na mestu injiciranja (vključno z rdečino in srbenjem) so bile pri večini bolnikov blage.
RA patients have an increased risk for cardiovascular disorders and risk factors (e.g. hypertension, hyperlipidaemia) should be managed as part of usual standard of care. 
Bolniki z RA imajo večje tveganje za srčno-žilne bolezni in dejavnike tveganja za slednje (npr. hipertenzijo, hiperlipidemijo) je treba obvladovati v okviru običajne standardne zdravstvene oskrbe.
• You will need an alcohol wipe, a cotton ball or gauze, and a puncture-resistant container. 
• Potrebovali boste alkoholni listič, kosem vate ali zloženec iz gaze in vsebnik za ostre odpadke.
The efficacy of sarilumab with concomitant DMARDs on inhibition of radiographic progression that was assessed as part of the primary endpoints at Week 52 in MOBILITY was sustained up to three years from the start of treatment. 
Učinkovitost sarilumaba s sočasnimi DMARD za zavrtje rentgenografskega napredovanja, ocenjeno kot del primarnih opazovanih dogodkov po 52 tednih študije MOBILITY, se je ohranilo do tri leta od začetka zdravljenja.
No cases of Hepatitis B reactivation were reported in the clinical studies; however patients who were at risk for reactivation were excluded. 
V kliničnih študijah niso zabeležili reaktivacije hepatitisa B, vendar pa je treba pri tem upoštevati, da bolniki s tveganjem za reaktivacijo v te študije niso bili vključeni.
Prepare the injection site. 
Pripravite mesto za injiciranje.
Immunogenicity As with all therapeutic proteins, there is a potential for immunogenicity with Kevzara. 
Imunogenost Tako kot pri vseh terapevtskih beljakovinah tudi pri zdravilu Kevzara obstaja možnost imunogenosti.
What you need to know before you use Kevzara 3. 
Kaj morate vedeti, preden boste uporabili zdravilo Kevzara 3.
In particular, do not use Kevzara and tell your doctor or pharmacist if you are using: 
Še zlasti ne uporabite zdravila Kevzara ter zdravnika ali farmacevta obvestite, če uporabljate:
• Your doctor, pharmacist, or nurse will show you how to inject Kevzara. 
• Zdravnik, farmacevt ali medicinska sestra vam bo pokazal(a), kako injicirati zdravilo Kevzara.
The most commonly reported infections (5% to 7% of patients) were upper respiratory tract infections, urinary tract infections, and nasopharyngitis. 
Najpogosteje zabeležene okužbe (pri 5 do 7 % bolnikov) so bile okužbe zgornjih dihal, okužbe sečil in nazofaringitis.
Hypersensitivity to the active substance or any of the excipients listed in section 6.1. 
Preobčutljivost za zdravilno učinkovino ali katero koli pomožno snov, navedeno v poglavju 6.1.
• you have had viral hepatitis or other liver disease. 
• ste imeli virusni hepatitis ali kakšno drugo bolezen jeter.
• That Kevzara treatment may increase the risks of serious infections, neutropenia and intestinal perforation. 
• Da lahko zdravljenje z zdravilom Kevzara poveča tveganje za resne okužbe, nevtropenijo in perforacijo črevesa.
Kevzara is not recommended in children and adolescents under 18 years of age. 
Zdravilo Kevzara ni priporočljivo za otroke in mladostnike, mlajše od 18 let.
• high cholesterol, high triglycerides shown by blood tests 
• visok holesterol, visoki trigliceridi (oboje se pokaže na preiskavi krvi)
ANC less than 0.5 
AŠN manj kot 0,5
Treatment with sarilumab resulted in decreases in fibrinogen and serum amyloid A, and increases in haemoglobin and serum albumin. 
Zdravljenje s sarilumabom je povzročilo znižanje fibrinogena in serumskega amiloida A ter zvišanje hemoglobina in serumskega albumina.
Sarilumab is eliminated by parallel linear and non-linear pathways. 
Sarilumab se izloča vzporedno po linearni in nelinearni poti.
• Educate patients on signs or symptoms that could represent serious infections or gastrointestinal perforations to seek for medical attention immediately. 
• Seznanitev bolnikov z znaki in simptomi, ki bi lahko pomenili resne okužbe ali perforacijo črevesa, z navodilom, da morajo v takšnem primeru nemudoma poiskati zdravniško pomoč.
• oral contraceptives 
• peroralne kontraceptive,
The most frequently observed serious infections included pneumonia and cellulitis. 
Najpogosteje zabeleženi resni okužbi sta bili pljučnica in celulitis.
If it has been 4 days or more since the missed dose, the subsequent dose should be administered at the next regularly scheduled time, the dose should not be doubled. 
Če so od izpuščenega odmerka minili 4 dnevi ali več, je treba naslednji odmerek uporabiti ob naslednjem redno predvidenem času; odmerka se ne sme podvojiti.
Do not get rid of any air bubbles in the syringe. 
Ne odstranjujte morebitnih zračnih mehurčkov v brizgi.
If it has been 4 days or more, inject the next dose at your regular time. 
Če so od izpuščenega odmerka minili 4 dnevi ali več, injicirajte naslednji odmerek ob običajnem času.
Fertility studies conducted in male and female mice using a murine surrogate antibody against mouse IL-6Rα showed no impairment of fertility. 
Študije plodnosti, izvedene pri mišjih samcih in samicah z uporabo mišjega nadomestnega telesa proti mišjemu IL-6Rα, niso pokazale okvare plodnosti.
As a monoclonal antibody sarilumab is expected to be degraded into small peptides and amino acids via catabolic pathways in the same manner as endogenous IgG. 
Ker je sarilumab monoklonsko protitelo, je mogoče pričakovati, da se razgradi v majhne peptide in aminokisline po kataboličnih poteh, enako kot endogeni IgG.
The excretion of sarilumab in Cynomolgus monkey's milk has not been studied. 
Izločanja sarilumaba v mleko pri opicah Cynomolgus niso raziskali.
• Based on the pharmacodynamics of the changes in ANC, use results obtained at the end of the dosing interval when considering dose modification (see section 5.1). 
• Na osnovi farmakodinamike sprememb AŠN, pri prilagajanju odmerka uporabite izvide, dobljene ob koncu odmernega intervala (glejte poglavje 5.3).
Do not use if the window is solid yellow. 
Ne uporabljate, če je okence rumeno.
Major clinical response¶ 
Večji klinični odziv¶
The results of the components of the ACR response criteria at Week 24 for MOBILITY and TARGET are shown in Table 4. 
Rezultati komponent meril odziva ACR po 24 tednih v študijah MOBILITY in TARGET so prikazani v preglednici 4.
• Carefully follow the “Instructions for Use” provided in the carton. 
• Natančno upoštevajte "Navodila za uporabo", priložena v škatli.
Low Absolute Neutrophil Count (see section 5.1) Lab Value (cells x 109/L) Recommendation 
Majhno absolutno število nevtrofilcev (glejte poglavje 5.1) Laboratorijska vrednost (celic x 109/l)
Put the yellow needle cover on your skin at roughly a 90° angle. 
Namestite rumeni pokrovček igle ob kožo pod kotom približno 90 stopinj.
Patients with latent or active tuberculosis should be treated with standard antimycobacterial therapy before initiating Kevzara. 
Bolnike z latentno ali aktivno tuberkulozo je treba pred uvedbo zdravila Kevzara zdraviti s standardnim protimikobakterijskim zdravljenjem.
It is unknown whether sarilumab is excreted in human milk or absorbed systemically after ingestion. 
Ni znano, ali se sarilumab pri človeku izloča v materinem mleku in ali se po zaužitju sistemsko absorbira.
Increased frequency and magnitude of these elevations were observed when potentially hepatotoxic medicinal products (e.g., MTX) were used in combination with Kevzara. 
Večjo pogostnost in velikost teh zvišanj so opažali, če so bila v kombinaciji z zdravilom Kevzara uporabljena potencialno hepatotoksična zdravila (npr. metotreksat).
What Kevzara is and what it is used for 2. 
Kaj je zdravilo Kevzara in za kaj ga uporabljamo 2.
Do not dispose of your used puncture-resistant container in your household waste unless your local guidelines permit this. 
Ne zavrzite uporabljenega vsebnika za ostre odpadke med gospodinjske odpadke (razen če to dovoljujejo vaši lokalni predpisi).
Various in vitro and limited in vivo human studies have shown that cytokines and cytokine modulators can influence the expression and activity of specific cytochrome P450 (CYP) enzymes (CYP1A2, CYP2C9, CYP2C19, and CYP3A4) and therefore have the potential to alter the pharmacokinetics of concomitantly administered medicinal products that are substrates of these enzymes. 
Različne humane študije in vitro in maloštevilne in vivo so pokazale, da lahko citokini in citokinski modulatorji vplivajo na izraženost in aktivnost specifičnih encimov citokroma P450 (CYP) (CYP1A2, CYP2C9, CYP2C19 in CYP3A4) in tako lahko spremenijo farmakokinetiko sočasno uporabljenih zdravil, ki so substrati teh encimov.
Kevzara can lower your body's ability to fight infection: this means it can make you more likely to get infections or make your infection worse. 
Zdravilo Kevzara lahko zmanjša sposobnost telesa za premagovanje okužb: to pomeni, da lahko poveča vašo dovzetnost za okužbe, ali vam okužbo poslabša.
However, if you are feeling tired or unwell after you use Kevzara, you should not drive or use machines. 
Toda če se po uporabi zdravila počutite utrujeni ali se ne počutite dobro, ne upravljajte vozil in strojev.
Do not use the syringe if the date has passed. 
Ne uporabite brizge, če je ta datum že mimo.
The recommended dose is one 200 mg injection every two weeks. 
Priporočeni odmerek je ena injekcija 200 mg na dva tedna.
Do not heat the pen; let it warm up on its own. 
Ne segrevajte peresnika: pustite, da se ogreje sam.
Do not stop using Kevzara without talking to your doctor. 
Ne prenehajte uporabljati zdravila Kevzara, ne da bi se prej posvetovali z zdravnikom.
(see section 5.2).Interaction of sarilumab with substrates of other CYPs (CYP2C9, CYP 2C19, CYP2D6) has not been studied. 
Medsebojnih delovanj sarilumaba s substrati drugih CYP (CYP2C9, CYP 2C19, CYP2D6) niso raziskali.